Tuesday 13 October 2026
Export all NUS data to Excel Powerpack
Nu Skin Enterprises, Inc.
NUS Consumer Defensive Household & Personal Products
Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.87
0.13
+2.74%
Follow NUS
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 23.51 | 47.10 | 56.09 | 35.03 | 12.31 | 39.40 | 29.96 | 16.15 | 5.95 | 5.32 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 66.04 | 70.27 | 88.68 | 69.79 | 57.01 | 63.85 | 56.76 | 45.55 | 20.75 | 14.62 | |||||
| People | |||||||||||||||
| People | Employees | 4,650 | 4,700 | 4,900 | 4,900 | 5,000 | 4,600 | 3,800 | 3,700 | 3,100 | 2,800 | ||||
| Revenue/emp, $m | 0.47 | 0.48 | 0.55 | 0.49 | 0.52 | 0.59 | 0.59 | 0.53 | 0.56 | 0.53 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 2,208 | 2,279 | 2,679 | 2,420 | 2,582 | 2,696 | 2,226 | 1,969 | 1,732 | 1,485 | ||||
| Gross margin, % | 77.33 | 77.97 | 76.33 | 75.98 | 74.51 | 74.95 | 71.65 | 68.93 | 68.23 | 69.45 | |||||
| EBT | 213 | 266 | 220 | 255 | 256 | 232 | 89 | 27 | (175) | 196 | |||||
| EBT margin, % | 9.64 | 11.65 | 8.20 | 10.54 | 9.92 | 8.62 | 4.00 | 1.35 | (10.11) | 13.21 | |||||
| Net income | 143 | 129 | 122 | 174 | 191 | 147 | 105 | 9 | (147) | 160 | |||||
| Depreciation | 72 | 72 | 83 | 77 | 74 | 76 | 73 | 71 | 70 | 52 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 39.84 | 43.16 | 48.56 | 43.60 | 49.37 | 53.71 | 44.51 | 39.61 | 34.88 | 30.13 | ||||
| Earnings | 2.58 | 2.45 | 2.21 | 3.13 | 3.66 | 2.93 | 2.10 | 0.17 | (2.95) | 3.25 | |||||
| Cash flow | 4.97 | 5.73 | 3.67 | 3.20 | 7.25 | 2.82 | 2.16 | 2.39 | 2.25 | 1.63 | |||||
| Capex | (0.91) | (1.14) | (1.28) | (1.19) | (1.22) | (1.37) | (1.18) | (1.18) | (0.84) | (0.70) | |||||
| Free cash flow | 4.06 | 4.59 | 2.40 | 2.01 | 6.03 | 1.45 | 0.98 | 1.21 | 1.41 | 0.93 | |||||
| Book value | 11.98 | 13.34 | 14.17 | 15.77 | 17.10 | 18.19 | 17.95 | 16.53 | 13.12 | 16.34 | |||||
| Shares, m | 55 | 53 | 55 | 56 | 52 | 50 | 50 | 50 | 50 | 49 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 18.83 | 27.98 | 27.63 | 13.13 | 14.73 | 17.38 | 20.12 | 112.89 | 0.00 | 2.97 | ||||
| P/S | 1.22 | 1.59 | 1.26 | 0.94 | 1.11 | 0.95 | 0.95 | 0.51 | 0.20 | 0.32 | |||||
| P/B | 4.07 | 5.14 | 4.33 | 2.60 | 3.19 | 2.79 | 2.35 | 1.23 | 0.53 | 0.59 | |||||
| EV/Sales | 1.25 | 1.57 | 1.28 | 0.95 | 1.07 | 0.95 | 1.00 | 0.63 | 0.31 | 0.31 | |||||
| EV/FCF | 12.23 | 14.73 | 25.81 | 20.50 | 8.78 | 35.20 | 45.64 | 20.70 | 7.67 | 9.97 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 275 | 303 | 203 | 178 | 379 | 142 | 108 | 119 | 112 | 80 | ||||
| Capex | (50) | (60) | (70) | (66) | (64) | (69) | (59) | (58) | (42) | (34) | |||||
| Free cash flow | 225 | 242 | 132 | 112 | 315 | 73 | 49 | 60 | 70 | 46 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 315 | 330 | 360 | 383 | 360 | 343 | 401 | 373 | 242 | 284 | ||||
| Total debt | 417 | 389 | 430 | 362 | 335 | 376 | 402 | 503 | 394 | 224 | |||||
| Net debt | 49 | (50) | 32 | 18 | (89) | 21 | 124 | 235 | 196 | (16) | |||||
| Shareholders’ equity | 664 | 705 | 782 | 875 | 894 | 913 | 897 | 822 | 651 | 805 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 9.60 | 8.45 | 7.42 | 10.02 | 10.27 | 7.62 | 5.62 | 0.47 | (8.95) | 11.15 | ||||
| ROIC | 20.26 | 26.19 | 18.49 | 18.71 | 19.98 | 15.65 | 6.78 | 2.85 | (11.18) | 5.21 | |||||
| ROE | 19.21 | 18.91 | 16.40 | 20.95 | 21.63 | 16.30 | 11.58 | 1.00 | (19.90) | 22.00 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Nu Skin Enterprises, Inc. vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| HELE Helen of Troy Limited | $620.1M | — (loss-making) | 9.3× | +2.12% (above 0%: growing) | n/m | −114.24% (below 0%: shrinking) | 52.19% | 5.20% | Compare |
| HNST The Honest Company, Inc. | $543.9M | — (loss-making) | 105× | −10.87% (below 0%: shrinking) | +233.33% (above 0%: growing) | +3,911.74% (above 0%: growing) | 48.45% | 11.50% | Compare |
| MAGN Magnera Corporation | $411.7M | — (loss-making) | — (loss-making) | +2.15% (above 0%: growing) | n/m | −115.38% (below 0%: shrinking) | 13.07% | 2.57% | Compare |
| ACU Acme United Corporation. | $238.3M | 24.2× | 31.0× | +16.15% (above 0%: growing) | +4.76% (above 0%: growing) | +155.61% (above 0%: growing) | 42.55% | 10.89% | Compare |
| NUS Nu Skin Enterprises, Inc. | $230.7M | — (loss-making) | 5.9× | −17.10% (below 0%: shrinking) | n/m | −86.06% (below 0%: shrinking) | 68.20% | (18.53%) | |
| YSG Yatsen Holding Limited Sponsored ADR | $164.5M | — (loss-making) | 32.2× | +10.97% (above 0%: growing) | n/m | +14.56% (above 0%: growing) | 73.88% | (11.55%) | Compare |
| MLKMF Waldencast PLC | $111.9M | — (loss-making) | — (loss-making) | — | n/m | −345.38% (below 0%: shrinking) | 46.91% | 0.00% | Compare |
| SLSN Solesence, Inc. | $72.1M | — (loss-making) | — | −24.69% (below 0%: shrinking) | n/m | +86.52% (above 0%: growing) | 30.97% | 0.79% | Compare |
| SKIN SkinHealth Systems Inc. | $71.6M | — (loss-making) | — (loss-making) | −7.77% (below 0%: shrinking) | n/m | −81.89% (below 0%: shrinking) | 68.42% | 4.95% | Compare |
| Median of peers | $201.4M | — | 31.6× | +2.12% | — | −33.66% | 47.68% | 3.76% |
Nu Skin Enterprises, Inc. (NUS) key facts
- Concern: Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024.
- Nu Skin Enterprises, Inc. (NUS) is a Household & Personal Products company in the Consumer Defensive sector, listed on the New York Stock Exchange.
- Net income was $160.2 million, or $3.25 per share (basic), a net margin of 10.8%.
- As of October 12, 2026, NUS traded at $4.87, a market capitalization of $237.1 million.
- Nu Skin Enterprises, Inc. pays an annual dividend of $0.24 per share, a yield of 4.93%.
- Return on equity was 22.0% and debt-to-equity 0.39.
- Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.78 (safe zone) for fiscal 2025.